| AGE-RAGE signaling pathway in diabetic complications |
2.01e-23 |
3.51e-21 |
7.18e-22 |
17 |
| Fluid shear stress and atherosclerosis |
9.03e-21 |
7.90e-19 |
1.62e-19 |
17 |
| IL-17 signaling pathway |
3.73e-20 |
2.17e-18 |
4.45e-19 |
15 |
| Chagas disease (american trypanosomiasis) |
1.62e-19 |
7.11e-18 |
1.45e-18 |
15 |
| TNF signaling pathway |
5.36e-19 |
1.88e-17 |
3.84e-18 |
15 |
| Toxoplasmosis |
8.18e-19 |
2.39e-17 |
4.88e-18 |
15 |
| Leishmaniasis |
5.66e-18 |
1.42e-16 |
2.89e-17 |
13 |
| Human cytomegalovirus infection |
3.92e-17 |
8.57e-16 |
1.75e-16 |
17 |
| Kaposi sarcoma-associated herpesvirus infection |
5.41e-17 |
1.05e-15 |
2.15e-16 |
16 |
| C-type lectin receptor signaling pathway |
6.07e-16 |
1.06e-14 |
2.17e-15 |
13 |
| Th17 cell differentiation |
8.91e-16 |
1.42e-14 |
2.90e-15 |
13 |
| Tuberculosis |
9.83e-16 |
1.43e-14 |
2.93e-15 |
15 |
| Nod-like receptor signaling pathway |
1.22e-14 |
1.56e-13 |
3.18e-14 |
14 |
| Malaria |
1.25e-14 |
1.56e-13 |
3.18e-14 |
10 |
| Apoptosis |
2.19e-14 |
2.55e-13 |
5.22e-14 |
13 |
| Pertussis |
2.80e-14 |
3.06e-13 |
6.27e-14 |
11 |
| Inflammatory bowel disease |
2.58e-13 |
2.65e-12 |
5.43e-13 |
10 |
| Osteoclast differentiation |
3.36e-13 |
3.27e-12 |
6.68e-13 |
12 |
| Nf-kappa B signaling pathway |
3.60e-13 |
3.32e-12 |
6.78e-13 |
11 |
| Influenza A |
4.39e-13 |
3.84e-12 |
7.86e-13 |
13 |
